Table 3.
All subjects (n = 70) | Early surgery (n = 35) | No early surgery (n = 35) | p Value | OR (95% CI) | |
ASCA | |||||
ASCA IgA (No (%)) | 29 (41.4) | 22 (62.9) | 7 (20.0) | 0.001* | 8.50 (2.02–75.85) |
ASCA IgG (No (%)) | 19 (27.1) | 14 (40.0) | 5 (14.3) | 0.027* | 5.50 (1.20–51.07) |
ASCA IgA and IgG (No (%)) | 18 (25.7) | 13 (37.1) | 5 (14.3) | 0.043* | 5.00 (1.07–46.93) |
DNAse sensitive pANCA (No (%)) | 15 (21.4) | 5 (14.3) | 10 (28.6) | 0.423 | 0.56 (0.15–1.85) |
OmpC (No (%)) | 14 (20.0) | 4 (11.4) | 10 (28.6) | 0.114 | 0.250 (0.03–1.25) |
*Statistically significant.
ASCA, anti-Saccharomyces cerevisiae antibodies; pANCA, perinuclear antineutrophil cytoplasmic antibodies; OmpC, Escherichia coli outer membrane porin C; Ig, immunoglobulin.
OR (95% CI), odds ratio (95% confidence interval).